I know some of you don’t like AI answers but here is what
I know some of you don’t like AI answers but here is what ChatGPT says. Not sure how reliable this answer is:
Is FDA Fast Track designation still in place for Leronlimab or has it expired or been revoked?
As of April 2025, there is no publicly available information indicating that the FDA’s Fast Track designations for leronlimab have been revoked or have expired. Leronlimab received Fast Track designation from the FDA in May 2019 for two indications:  
1. Combination Therapy with HAART for HIV-Infected Patients: This designation aimed to expedite the development of leronlimab as part of a combination treatment for HIV.
2. Treatment of CCR5-Positive Metastatic Triple-Negative Breast Cancer (mTNBC): Leronlimab was granted Fast Track status for use in combination with carboplatin for patients with this specific type of breast cancer. 
While CytoDyn, the developer of leronlimab, voluntarily withdrew its Biologics License Application (BLA) for leronlimab as a combination therapy for HIV in October 2022 due to data collection and monitoring issues, there have been no reports indicating that the Fast Track designations themselves have been revoked or have expired. 
Furthermore, in March 2025, the FDA cleared the initiation of a Phase 2 study evaluating leronlimab for the treatment of patients with microsatellite-stable relapsed/refractory metastatic colorectal cancer, suggesting ongoing regulatory engagement with the drug’s development. 
Therefore, based on the available information, the Fast Track designations for leronlimab remain in place.
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Top 5 Most Recently Viewed Articles
Knowtex Partners with U.S. Department of Veterans Affairs Women-founded, YC-backed company, Knowtex brings ambient AI to the nation's largest integrated healthcare system SAN FRANCISCO — Knowtex, a frontrunner in ambient clinical intelligence, has secured a substantial contract with the U.S. Department of Veterans Affairs (VA) valued at $15 million. This achievement...
Continue Reading
Market Sentiment Around Upstart Holdings Inc Recently, Upstart Holdings Inc (NYSE: UPST) has witnessed a notable change in its short interest, which measures the percentage of shares sold short compared to the total float. The latest report indicates a reduction of 6.38% in this figure, resulting in approximately 23.62 million shares being sold short. This equates to...
Continue Reading
Exciting Changes Ahead for Husqvarna AB's Board of Directors The Nomination Committee of Husqvarna AB is gearing up for the company's annual general meeting, proposing significant changes to its Board of Directors. Recently, it was announced that three members will not seek re-election, paving the way for fresh leadership and diverse perspectives. This move reflects the...
Continue Reading
Mirantis OpenStack for Kubernetes 24.3 Released Mirantis, a provider of open-source software that gives organizations comprehensive control over their infrastructure, has recently announced the launch of Mirantis OpenStack for Kubernetes (MOSK) 24.3. This latest version stands out as the first to deliver enterprise-grade OpenStack Caracal, specifically crafted to cater to...
Continue Reading
Understanding DoorDash's Recent Options Activity Heavyweight investors are demonstrating a bullish stance towards DoorDash (NASDAQ: DASH). This shift in sentiment should draw the attention of market players. Insights gathered from our observations reveal a notable surge in options activity surrounding DASH. Recent Trading Insights On our watch, there have been 23...
Continue Reading